Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study

León Mateos, Luis Ángel

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/2061

ISSN: 0732-183X

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

Journal Of Clinical Oncology

Type of content

Publicación de congreso